These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 289865

  • 1. Angiotensin II blockade: evidence for baroreceptor-mediated renin release and the role of sodium balance.
    Baer L, Parra-Carrillo JZ, Radichevich I.
    Kidney Int Suppl; 1979 Mar; (9):S60-7. PubMed ID: 289865
    [No Abstract] [Full Text] [Related]

  • 2. Angiotensin II blockade by saralasin in the evaluation of hypertension in children.
    Favre L, Boerth RC, Braren V, Dean RH, Hollifield JW.
    Kidney Int Suppl; 1979 Mar; (9):S75-82. PubMed ID: 289867
    [No Abstract] [Full Text] [Related]

  • 3. Hemodynamic correlates of saralasin: responsiveness in hypertension.
    Kem DC, Frohlich ED, de Carvalho JG, Dunn FG, Chrysant SG, Danisa K, Wambach G.
    Kidney Int Suppl; 1979 Mar; (9):S68-74. PubMed ID: 289866
    [No Abstract] [Full Text] [Related]

  • 4. Angiotensin as a renal, adrenal, and cardiovascular hormone: responses to saralasin in normal man and in essential and secondary hypertension.
    Hollenberg NK, Williams GH.
    Kidney Int Suppl; 1979 Mar; (9):S29-35. PubMed ID: 384070
    [No Abstract] [Full Text] [Related]

  • 5. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF, Russell GI, Swales JD, Thurston H.
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [Abstract] [Full Text] [Related]

  • 6. Saralasin in human hypertension: the early experience.
    Brunner HR, Laragh JH.
    Kidney Int Suppl; 1979 Mar; (9):S36-43. PubMed ID: 289862
    [No Abstract] [Full Text] [Related]

  • 7. Outpatient experience with saralasin.
    Streeten DH, Anderson GH.
    Kidney Int Suppl; 1979 Mar; (9):S44-52. PubMed ID: 289863
    [No Abstract] [Full Text] [Related]

  • 8. Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balance.
    Brunner HR, Gavras H, Ribeiro AB, Posternak L.
    Prog Biochem Pharmacol; 1976 Mar; 12():145-62. PubMed ID: 1019161
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin blockade by saralasin bolus injection.
    Maxwell MH, Marks LS.
    Kidney Int Suppl; 1979 Mar; (9):S53-9. PubMed ID: 289864
    [No Abstract] [Full Text] [Related]

  • 10. Drug interactions with saralasin.
    Mitchell HC, Keeton TK, Pettinger WA.
    Kidney Int Suppl; 1979 Mar; (9):S101-6. PubMed ID: 289859
    [Abstract] [Full Text] [Related]

  • 11. Comparison of renal vein renin activity in hypertensive patients with stenosis of one or both renal arteries.
    Pickering TG, Sos TA, James GD, Vaughan ED, Sealey JE, Laragh JH.
    J Hypertens Suppl; 1985 Dec; 3(3):S291-3. PubMed ID: 2856720
    [Abstract] [Full Text] [Related]

  • 12. [Renovascular hypertension: prediction of surgical treatment by angiotensin II blockade and saralasin (author's transl)].
    Mimran A, Deschodt G, Barjon P, Mary H, Thevenet A.
    Nouv Presse Med; 1978 Dec 02; 7(43):3889-93. PubMed ID: 733540
    [Abstract] [Full Text] [Related]

  • 13. The role of the renin-angiotensin system in hypertension.
    Robertson JI.
    Semin Nephrol; 1988 Jun 02; 8(2):120-30. PubMed ID: 3293136
    [No Abstract] [Full Text] [Related]

  • 14. Saralasin infusion in renovascular and essential hypertension.
    Thien T, Hoefnagels WH.
    Neth J Med; 1980 Jun 02; 23(2):68-73. PubMed ID: 6990282
    [No Abstract] [Full Text] [Related]

  • 15. The pathophysiology of renin release in renovascular hypertension.
    Welch WJ.
    Semin Nephrol; 2000 Sep 02; 20(5):394-401. PubMed ID: 11022891
    [Abstract] [Full Text] [Related]

  • 16. Role of the renin-angiotensin system in renal hypertension. An experimental approach.
    Helmchen U, Kneissler U.
    Curr Top Pathol; 1976 Sep 02; 61():203-38. PubMed ID: 1248262
    [No Abstract] [Full Text] [Related]

  • 17. Reactive hyperreninemia in renovascular hypertension after angiotensin blockage with saralasin or converting enzyme inhibitor.
    Case DB, Laragh JH.
    Ann Intern Med; 1979 Aug 02; 91(2):153-60. PubMed ID: 464461
    [Abstract] [Full Text] [Related]

  • 18. Pharmacologic probes to identify patients with renovascular hypertension.
    Sosa RE, Vaughan ED.
    Semin Urol; 1985 Nov 02; 3(4):317-24. PubMed ID: 2887024
    [Abstract] [Full Text] [Related]

  • 19. Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension.
    Marks LS, Maxwell MH, Kaufman JJ.
    Ann Intern Med; 1977 Aug 02; 87(2):176-82. PubMed ID: 889198
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin antagonists as diagnostic and pharmacologic tools.
    Pettinger WA, Mitchell HC.
    Prog Biochem Pharmacol; 1976 Aug 02; 12():203-13. PubMed ID: 798203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.